TET2 and chronic myelomonocytic leukemia: TET-2 mutations (Ten-eleven translocation 2) were originally described in myeloid malignancies, such as myelodysplastic syndromes (MDS), chronic myelomonocytic leukemias (CMML), and acute myeloid leukemias (AML).